Perfluorohexyloctane - Indication, Pharmacology, Warnings, and Precautions

Overview:

Perfluorohexyloctane was given the United States Food and Drug Administration’s license for its use in those who struggle with dry eye disease symptoms. This approval was granted in 2023, and it was given because the study report with Perfluorohexyloctane in dry eye disease cases was appreciable and acceptable. Eye irritation can be distressing and frustrating, and Perfluorohexyloctane has become a boon for patients with dry eye disease to have a quality life.

Available Doses and Dosage Forms:

The ophthalmic solution, or eye drop, is the dosage form in which Perfluororhexylocatane is used for this purpose. This ophthalmic solution is not meant to be taken orally or in any way other than through topical application to the eyes. Another peculiarity is that in this medicine, the drug molecule Perfluorohexyloctane is present in 100 percent, and no other diluent is included.

For Patients:

How Does Perfluorohexyloctane Work for Dry Eye Disease?

Perfluorohexyloctane ophthalmic solution can prevent or reduce the loss of tears through evaporation. In dry eye disease, eye lubrication will be minimal, possibly due to reduced tear production or increased tear evaporation. Sometimes, a combination of both could be the reason for that. Perfluorohexyloctane can prevent the tear from getting evaporated and lost. Since this medicine is lipid-like, it can merge with the tear layer and act as a shield to prevent tear loss through evaporation.

What Is the Dosage of Perfluorohexyloctane?

One drop of Perfluorohexyloctane is the preferred dose and must be repeated four times daily.

How Effective Is Perfluorohexyloctane?

Perfluorohexyloctane can increase the stability of the eye’s tear layer, which is critical in keeping the eye lubricated and thereby protected. Symptomatic relief is the most highlighted aspect of Perfluorohexyloctane ophthalmic solution. The patients treated with this eye drop experienced severe and appreciable relief in dry eye disease signs and symptoms, making it the apt and best choice. Another appreciable aspect is its long relief period; it can provide relief for longer periods than other medical agents used for dry eye diseases. Despite having this many therapeutic values, Perfluorohexyloctane does not bring out any dangerous adverse outcomes following its usage. This acceptable safety profile has also contributed much to its patient application and use.

What Are the Things to Inform the Doctor Before Taking Perfluorohexyloctane?

Before taking Perfluorohexyloctane, just like any other medicine, its appropriateness and safety must be diligently considered for every patient, and that is why it is advised to keep the doctors informed and aware of certain critical information that can have an impact on the person’s health and wellness. The following are some key information to inform the doctor:

• A complete checklist of all the medicines that the patient takes.

• Previous allergic issues were noted with Perfluorohexyloctane, if any.

• Allergic issues were noted with other medicines or tablets.

• Medical conditions, if any, that are known to the person.

• Pregnancy status and its plans.

• Lactating or not.

How Is Perfluorohexyloctane Administered?

The administration of Perfluorohexyloctane is similar to that of other eye drops. It usually comes in a small bottle with a dropper tip. The dropper tip must have a cap that seals off the leakage of the solution. So first, the cap over the dropper tip must be removed. Following this, squeeze the container with finger pressure, but ensure it is held upright. With the pressure applied, bring the bottle upside down. In that position, the squeezing can be stopped so that some air bubbles may get into the container. Maintain the bottle upside-down, then bring it directly above the eye. Squeeze the bottle a bit so that a single drop of Perfluorohexyloctane can be released. Since the bottle is directly above the eye, the eye can capture the drop and accommodate it within. Ensure that the hands are washed and cleaned before and after. In addition, get off the contact lens, and no attempt should be made to get the eye drop with the contact lens on.

What Are the Side Effects of Perfluorohexyloctane?

Red eyes and blurry vision are noted; no other alarming effects came in.

Dietary Considerations:

Perfluorohexyloctane ophthalmic solution does not require any dietary alterations per se. However, it may differ with the person’s health profile, and if there is any consideration that the doctor has asked for, stick to it.

Missed Dose:

Missing dose scenarios may frequently happen with Perfluorohexyloctane. If the Perfluorohexyloctane dose is missed somehow, just like any other medicine, try to get it as soon as it is realized. If a dose missing is noted when the subsequent dose is almost due, just forget about the missed dose and proceed as usual. Doubling the Perfluorohexyloctane dose is not a solution to compensate for it; therefore, no attempt should be made.

Overdose:

Perfluorohexyloctane, when administered to eyes at a dose that is way higher than the safety limit set for the person, can lead to overdose and its related problems. If more drops of Perfluorohexyloctane are delivered into the eyes, the doctors will treat it as soon as possible.

Storage:

68 to 77 degrees Fahrenheit is the best storage temperature specified for Perfluorohexyloctane eye drops.

For Doctors:

Indication:

Dry eye disease is a condition for which Perfluorohexyloctane administration is indicated in order to reduce the signs and discomfort that are associated with it.

Dose:

Unlike other medicines, where the dose is mentioned concerning the measurement of the drug, mostly in milligrams or milliliters, Perfluorohexyloctane is advised regarding the number of drops that must be delivered. One drop is recommended as the dose and must be repeated four times daily. In general, no dosing considerations have to be placed for Perfluorohexyloctane; however, it is primarily based on other disease conditions.

What Are the Pharmacological Aspects of Perfluorohexyloctane?

• Mechanism of Action: Perfluorohexyloctane blocks the evaporation of tear film by forming a protective layer by merging with the lipid layer of the tear layer, which is the tear film layer in contact with the atmospheric air. Thus, Perfluororhexylocatan stabilizes and strengthens the tear film. Doing this can keep the tear film intact and locked in and prevent its aqueous layer evaporation, reducing dry eye disease symptoms. Ocular surface integrity and health can thus be preserved and maintained with this eyedrop. It is the nonaqueous nature of the eye drop that makes it best suited for dye eye disease. The lipid layer this eye drop medicine sets prevents environmental irritants from getting into the eyes.

• Pharmacodynamics: Perfluorohexyloctane is quite an unreactive and inert compound; therefore, it does not have the typical pharmacodynamics of other medicines. The perfluorinated structure enables its functions as an agent for dry eye disease. It blankets the ocular surface and keeps the tear film intact, thus drying out the eye, and the grittiness that develops afterward can be prevented. Through these techniques, sufficient lubrication in the eye can be ensured. The biological inertness of Perfluorohexyloctane also reduces the scope of systemic negative effects, and thus, it is better tolerated with a better safety profile.

• Pharmacokinetics: The pharmacokinetics of Perfluorohexyloctane is quite different from other eye drops. It acts locally and intends to avoid being taken up into deeper layers of eyes. The drop forms a lipid layer and does not cross beyond the tear film; hence, the pharmacokinetic parameters regarding absorption, distribution, and metabolism are irrelevant in this case. The drug from the eye gets cleared off by its intrinsic clearance system, the natural tear drainage, and has no metabolic pathways.

Toxicity:

The carcinogenic potential of Perfluorohexyloctane is still unclear as no long-term investigations have been carried out. However, the Ames test report with the medicine was negative, reducing the possibility of mutagenic potential. However, that alone is not sufficient to confirm that it is completely free of toxicities.

What Are the Contraindications of Perfluorohexyloctane?

None.

Warnings and Precautions:

Strictly instruct and warn the patient that they should not have their contact lenses on while delivering the Perfluorohexyloctane eye drop. They have to take it off priority and can be placed back only after a minimum period of 30 minutes. Keeping the contact lenses on can influence the effectiveness of the eyedrop. Therefore, it has to be removed so that the eyedrop can successfully form a barrier layer without any obstruction.

What Are the Drug Interactions of Perfluorohexyloctane?

Due to its inertness, the scope for drug interaction with Perfluorohexyloctane is minimal. Similarly, it acts as a protective blanket for the tear film, so these drug molecules are not exposed systemically. Only if the drug molecule gets into the blood can it interact with other medicines, which is how drug interactions happen. Therefore, here with Perfluorohexyloctane, no appreciable interactions are seen. However, if many eye drops are available for the patient, just keep a gap of a few minutes between each eye drop to be safer.

Specific Considerations:

Perfluorohexyloctane eye drops are not for pregnant ones; however, no proven harmful effects can come with this eyedrop when used by a pregnant woman. But, at the same time, that does not mean it is safe and does not rule out the possibility of a negative pregnancy outcome to come out. The absence of relevant studies and study reports about its use in pregnancy is what limits its use in that particular patient group.

There is not much clarity on whether the Perfluorohexyloctane gets discharged through the breastmilk or whether it impacts the child whom the woman breastfeeds. However, the likelihood of such events is limited since the medicine is believed to not get into systemic circulation. However, the possibility can only partially be ruled off, as little evidence supports this hypothesis. Therefore, weighing the positives and negatives that this medicine could bring out on the patient is better, and then the doctor can decide.

Perfluorohexyloctane use in pediatric patients (under 18 years) is not recommendable; its safety aspects and efficacy properties in this age group are neither established nor determined. Therefore, it is better not to give this medicine to children and infants.

Though some medicines may have different effects on geriatric patients, Prfluorohexyloctane is not among them. The effects and impacts were similar to those of the adult population, and no specific adversities occurred in the geriatric population.

Clinical Studies:

Clinical studies with the Perfluorohexyloctane eyedrop gave out appreciable outcomes; the usage of this eyedrop notably reduced dry eye disease symptoms. In addition, no grave negatives were reported during the study, highlighting the eyedrop's safety profile, another critical element. Blurred vision was one of the side effects noticed, though only one to two percent developed it. Another noted one was conjunctival redness, which was rarely found. It was through randomized and double-blinded studies that these were evaluated, and it was carried out with the regular dose of one drop at a daily frequency of four times.

Perfluorohexyloctane eyedrops are a great boon for those with dry eye disease who are frustrated by the discomfort they cause. Its localized and contained actions can help limit its systemic exposure and thereby limit the adverse outcomes that accompany it.